New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide
October 12, 2015 at 16:01 PM EDT
Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) today presented additional findings from an exploratory sub-study of the ...